clinical trial · NCT06978244
A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy Volunteers
Ocular PainBL1332 ophthalmic solutionBL1332 ophthalmic vehicle
brief summary
Single-Center, Phase 1 study to assess the ocular and systemic safety and tolerability of ascending concentrations of topical BL1332 ophthalmic solution eye drops compared with BL1332 vehicle in healthy volunteers, identifying the highest tolerated doses (HTDs)
started
Jul 29, 2025
primary completion
Nov 1, 2026
completion
Nov 1, 2026
last updated
Jan 27, 2026
detailed description
To assess the ocular and systemic safety and tolerability of ascending concentrations of topical BL1332 ophthalmic solution eye drops compared with BL1332 vehicle in healthy volunteers, identifying the highest tolerated doses (HTDs)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol